The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature
Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer.
Main Authors: | , , , , |
---|---|
Format: | Online |
Language: | English |
Published: |
Wolters Kluwer Health
2016
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902403/ |
id |
pubmed-4902403 |
---|---|
recordtype |
oai_dc |
spelling |
pubmed-49024032016-06-23 The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature Ding, Lin Li, Qing-Jian You, Kai-Yun Jiang, Zhi-Min Yao, He-Rui 5700 Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer. Wolters Kluwer Health 2016-05-20 /pmc/articles/PMC4902403/ /pubmed/27196461 http://dx.doi.org/10.1097/MD.0000000000003598 Text en Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0 |
repository_type |
Open Access Journal |
institution_category |
Foreign Institution |
institution |
US National Center for Biotechnology Information |
building |
NCBI PubMed |
collection |
Online Access |
language |
English |
format |
Online |
author |
Ding, Lin Li, Qing-Jian You, Kai-Yun Jiang, Zhi-Min Yao, He-Rui |
spellingShingle |
Ding, Lin Li, Qing-Jian You, Kai-Yun Jiang, Zhi-Min Yao, He-Rui The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature |
author_facet |
Ding, Lin Li, Qing-Jian You, Kai-Yun Jiang, Zhi-Min Yao, He-Rui |
author_sort |
Ding, Lin |
title |
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature |
title_short |
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature |
title_full |
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature |
title_fullStr |
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature |
title_full_unstemmed |
The Use of Apatinib in Treating Nonsmall-Cell Lung Cancer: Case Report and Review of Literature |
title_sort |
use of apatinib in treating nonsmall-cell lung cancer: case report and review of literature |
description |
Apatinib is a novel tyrosine kinase inhibitor targeting vascular endothelial growth factor receptor-2, which has been proved to be effective and safe in treating heavily pretreated patients with gastric cancer. |
publisher |
Wolters Kluwer Health |
publishDate |
2016 |
url |
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4902403/ |
_version_ |
1613592977249140736 |